Search - tctmd.com

Displaying 141 - 160 of 247

Sort: Relevancy | Date

Presentation TVT 2019

Late-Presenting Migration of Sapien XT Into LVOT Treated With TF-VIV

Presenter: Jason Ricci

June 13, 2019

News Conference News EuroPCR 2019

Allegra TAVR System Feasible for Treating Degenerated Surgical Valves

Michael O'Riordan

May 29, 2019

Presentation ARCH 2019

Catheter Based Therapies After Surgical Mitral Interventions

Presenter: Alan Zajarias

April 12, 2019

Presentation ARCH 2019

A Glimpse at Boston Scientific’s Structural Heart Therapies PortfolioAdvanced Revascularization Chapter XII

Presenter: David G. Rizik

April 11, 2019

Presentation ARCH 2019

Transcatheter Valve in Valve implantation for Degenerated Surgical Bioprothesis Replacement

Presenter: Cho Mi Young

April 10, 2019

News Conference News ACC 2019

My Takeaways From ACC 2019: Breaking With Embargoes? Despite the Drama, Embargoes Set to Stay

Shelley Wood

April 05, 2019

Presentation SIF 2019

The Impact of Prior Cardiac Surgery on TAVR Outcomes

Presenter: Jeffrey A Southard

March 30, 2019

Presentation SIF 2019

So You Want to Crack a Valve–The How and the Who?

Presenter: Srinivas Iyengar

March 29, 2019

News Daily News

Could PET Imaging Be the ‘Game Changer’ for Detecting and Predicting Bioprosthetic Valve Degeneration?

Michael O'Riordan

March 13, 2019

News Conference News STS 2019

Redo Surgery for Bioprosthetic Aortic Valve Failure on the Decline Since 2015

Yael L. Maxwell

February 06, 2019

News Conference News VIVA 2018

Now You See Them, Now You Don’t: Bioresorbable Devices Target Large-Bore Closures and PE Prevention

L.A. McKeown

November 09, 2018

Presentation TCT 2018

The Watch TAVR Trial: Rationale, Design and Status

Presenter: Vivek Y. Reddy, Brian K. Whisenant, Samir R. Kapadia

September 24, 2018

Presentation TCT 2018

The WaveCrest Device and US Pivotal Trial

Presenter: Vivek Y. Reddy, Brian K. Whisenant, Gregg W. Stone

September 24, 2018

Presentation TCT 2018

The Amulet Platform, Experience and US Pivotal Trial

Presenter: Vivek Y. Reddy, Brian K. Whisenant, Apostolos Tzikas

September 24, 2018

Presentation TCT 2018

The Watchman Platform, ASAP Too and Flex: Rationale, Device and Overview of the Trials

Presenter: Vivek Y. Reddy, Brian K. Whisenant

September 24, 2018

Presentation TCT 2018

FDA Perspectives on New Devices and Indications for LAA Closure

Presenter: Vivek Y. Reddy, Brian K. Whisenant, Andrew Farb

September 24, 2018

Presentation TCT 2018

The LAAO Registry: Overview, Data Adjudication, and Emerging Insights

Presenter: Vivek Y. Reddy, Brian K. Whisenant, Paul D. Varosy

September 24, 2018

Presentation TCT 2018

Take-Home Messages: What Did We Learn From These Cases?

Presenter: Maurice Buchbinder, Vivek Y. Reddy

September 23, 2018

Presentation TCT 2018

Case #12: An LAA Exclusion Procedure Guided by Personalized Computer Modeling

Presenter: Maurice Buchbinder, Vivek Y. Reddy, Habib Gamra, Aaron V. Kaplan, Ulf Landmesser, Petr Neuzil, Jai-Wun Park, Kolja Sievert

September 23, 2018

Presentation TCT 2018

Case #11: Major Complication of an LAA Closure Procedure in a Frail, Elderly Patient

Presenter: Maurice Buchbinder, Vivek Y. Reddy, Habib Gamra, Aaron V. Kaplan, Ulf Landmesser, Petr Neuzil, Jai-Wun Park, Kolja Sievert

September 23, 2018

Advertisement

Late-Presenting Migration of Sapien XT Into LVOT Treated With TF-VIV

Allegra TAVR System Feasible for Treating Degenerated Surgical Valves

Catheter Based Therapies After Surgical Mitral Interventions

A Glimpse at Boston Scientific’s Structural Heart Therapies PortfolioAdvanced Revascularization Chapter XII

Transcatheter Valve in Valve implantation for Degenerated Surgical Bioprothesis Replacement

My Takeaways From ACC 2019: Breaking With Embargoes? Despite the Drama, Embargoes Set to Stay

The Impact of Prior Cardiac Surgery on TAVR Outcomes

So You Want to Crack a Valve–The How and the Who?

Could PET Imaging Be the ‘Game Changer’ for Detecting and Predicting Bioprosthetic Valve Degeneration?

Redo Surgery for Bioprosthetic Aortic Valve Failure on the Decline Since 2015

Now You See Them, Now You Don’t: Bioresorbable Devices Target Large-Bore Closures and PE Prevention

The Watch TAVR Trial: Rationale, Design and Status

The WaveCrest Device and US Pivotal Trial

The Amulet Platform, Experience and US Pivotal Trial

The Watchman Platform, ASAP Too and Flex: Rationale, Device and Overview of the Trials

FDA Perspectives on New Devices and Indications for LAA Closure

The LAAO Registry: Overview, Data Adjudication, and Emerging Insights

Take-Home Messages: What Did We Learn From These Cases?

Case #12: An LAA Exclusion Procedure Guided by Personalized Computer Modeling

Case #11: Major Complication of an LAA Closure Procedure in a Frail, Elderly Patient

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content